Diabetes Mellitus in Prader-Willi Syndrome: Natural History during the Transition from Childhood to Adulthood in a Cohort of 39 Patients
Authors:
- Alice ClercACAlice Clerc
- Muriel CoupayeMCMuriel Coupaye
- Héléna MosbahHMHéléna Mosbah
- Graziella PintoGPGraziella Pinto
- Virginie LaurierVLVirginie Laurier
- Fabien MourreFMFabien Mourre
- Christine MerrienCMChristine Merrien
- Gwenaëlle DieneGDGwenaëlle Diene
- Christine PoitouCPChristine Poitou
- Maithé TauberMTMaithé Tauber
Open Access
- 15 November 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (22) , 5310
Abstract
Type 2 diabetes mellitus (T2DM) affects 20% of patients with Prader-Willi syndrome (PWS), with many cases diagnosed during the transition period. Our aim was to describe the natural history of T2DM in patients with PWS before the age of 25 years and to develop screening and preventive strategies. Thirty-nine patients followed in the French PWS Reference Center were included (median age 25.6 years [23.7; 31.7]). Twenty-one had been treated with growth hormone (GH), fifteen had not, and three had an unknown status. The median age at T2DM diagnosis was 16.8 years (11–24) and the median BMI was 39 kg/m2 [34.6; 45], with 34/35 patients living with obesity. The patients displayed frequent psychiatric (48.3% hospitalization,) and metabolic (56.4% hypertriglyceridemia,) comorbidities and a parental history of T2DM (35.7%) or overweight (53.6%) compared to the PWS general population. There was no difference in BMI and metabolic complications between the GH-treated and non-GH-treated groups at T2DM diagnosis. Patients with PWS who develop early T2DM have severe obesity, a high frequency of psychiatric and metabolic disorders, and a family history of T2DM and overweight. These results underline the need for early identification of patients at risk, prevention of obesity, and repeated blood glucose monitoring during the transition period.Keywords
This publication has 46 references indexed in Scilit:
- Endocrine manifestations and management of Prader-Willi syndromeInternational Journal of Pediatric Endocrinology, 2013
- Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2013
- Nutritional phases in Prader–Willi syndromeAmerican Journal of Medical Genetics Part A, 2011
- The Metabolic Phenotype of Prader-Willi Syndrome (PWS) in Childhood: Heightened Insulin Sensitivity Relative to Body Mass IndexThe Journal of Clinical Endocrinology & Metabolism, 2011
- Endocrine Disorders in Children with Prader-Willi Syndrome – Data from 142 Children of the French DatabaseHormone Research in Paediatrics, 2010
- Energy expenditure and physical activity in Prader–Willi syndrome: Comparison with obese subjectsAmerican Journal of Medical Genetics Part A, 2006
- Insulin resistance and the metabolic syndrome in obese French childrenClinical Endocrinology, 2006
- Insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjectsClinical Genetics, 2004
- Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based studyDevelopmental Medicine & Child Neurology, 2002
- Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeksThe Journal of Pediatrics, 1969